171 related articles for article (PubMed ID: 24968996)
1. The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
Little MH; Reitmeir P; Peters A; Leidl R
Value Health; 2014 Jun; 17(4):364-71. PubMed ID: 24968996
[TBL] [Abstract][Full Text] [Related]
2. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
Couzner L; Crotty M; Norman R; Ratcliffe J
Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China.
Wang H; Cao C; Guo C; He Y; Li F; Xu R; Liu M; Liu Z; Pan Y; Liu F; Liu Y; Li J; Cai H; He Z; Ke Y
Health Qual Life Outcomes; 2020 Jul; 18(1):228. PubMed ID: 32660494
[TBL] [Abstract][Full Text] [Related]
5. Patient versus general population health state valuations: a case study of non-specific low back pain.
van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
[TBL] [Abstract][Full Text] [Related]
6. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
PLoS One; 2014; 9(11):e108434. PubMed ID: 25365171
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
8. Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea - a comparison with the general population preference weights.
Hong J
Health Qual Life Outcomes; 2018 Aug; 16(1):159. PubMed ID: 30075726
[TBL] [Abstract][Full Text] [Related]
9. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
10. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.
Franklin M; Payne K; Elliott RA
Med Decis Making; 2018 Jan; 38(1):79-94. PubMed ID: 29056069
[TBL] [Abstract][Full Text] [Related]
12. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
13. A comparison of individual and social time trade-off values for health states in the general population.
Burström K; Johannesson M; Diderichsen F
Health Policy; 2006 May; 76(3):359-70. PubMed ID: 16214258
[TBL] [Abstract][Full Text] [Related]
14. Inconsistencies in TTO and VAS values for EQ-5D health states.
Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
[TBL] [Abstract][Full Text] [Related]
15. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2018 Apr; 21(4):456-461. PubMed ID: 29680103
[TBL] [Abstract][Full Text] [Related]
16. Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.
Zrubka Z; Golicki D; Prevolnik-Rupel V; Baji P; Rencz F; Brodszky V; Gulácsi L; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):141-154. PubMed ID: 31102159
[TBL] [Abstract][Full Text] [Related]
17. Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.
Ratcliffe J; Longworth L; Young T; Bryan S; Burroughs A; Buxton M;
Liver Transpl; 2002 Mar; 8(3):263-70. PubMed ID: 11910572
[TBL] [Abstract][Full Text] [Related]
18. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease.
Leidl R; Reitmeir P; König HH; Stark R
Value Health; 2012 Jan; 15(1):151-7. PubMed ID: 22264983
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
20. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.
Zrubka Z; Beretzky Z; Hermann Z; Brodszky V; Gulácsi L; Rencz F; Baji P; Golicki D; Prevolnik-Rupel V; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):119-132. PubMed ID: 31104218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
